Beta Amyloid Peptide is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Beta Amyloid Peptide is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Beta-amyloid (Aβ) is a 38-43 amino acid peptide derived from the Amyloid Precursor Protein (APP) through sequential proteolytic cleavage by [β-secretase](/entities/bace1) and [γ-secretase](/entities/gamma-secretase). Aβ is the main component of amyloid plaques in Alzheimer's disease and is central to the amyloid cascade hypothesis.
Generation
APP Processing
Amyloidogenic pathway (Aβ-generating):
β-secretase (BACE1) cleaves at the N-terminus of Aβ → produces sAPPβ + C99
APP/PSEN mutations cause familial AD with increased Aβ production
APP duplication causes AD-type dementia
Aβ immunotherapy reduces plaques and may slow decline (in some trials)
Evidence challenging:
Poor correlation between plaque load and cognitive impairment
Many elderly have plaques but no dementia
Anti-Aβ therapies have largely failed to improve cognition
Cerebral Amyloid Angiopathy (CAA)
Aβ1-40 deposits in cerebral blood vessel walls
Causes hemorrhages, microinfarcts, white matter damage
Common comorbidity with AD
Therapeutic Targeting
Immunotherapy Approaches
Secretase Modulators
Anti-aggregation
Small molecules to prevent oligomerization
Peptide inhibitors
Antibody approaches targeting oligomers
Key Publications
[Structure of Aβ42 fibrils](https://doi.org/10.1038/nature25479) - A. W. Fitzpatrick, 2017
[Aβ oligomer toxicity](https://doi.org/10.1016/j.neuron.2012.03.025) - S. T. Ferreira, 2015
[Aducanumab approval](https://doi.org/10.1038/s41586-021-03825-3) - S. Budd Haeberlein, 2021
[Lecanemab CLARITY trial](https://doi.org/10.1056/NEJMoa2212948) - C. H. van Dyck, 2023
Background
The study of Beta Amyloid Peptide has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
[Allen Human Brain Atlas: Beta-amyloid](https://human.brain-map.org/microarray/search/show?search_term=beta-amyloid)
[Allen Cell Type Atlas: Beta-amyloid](https://celltype.brain-map.org/)